Officer-Production

Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to customers across geographies. The business is organized into two segments - Specialty Pharmaceuticals and Generics & APIs. Jubilant Generics (JGL) is a wholly-owned subsidiary of Jubilant Pharma with Research & Development units in Noida and Mysore, India. The company operates manufacturing facilities in Mysore, Karnataka, and Roorkee, Uttarakhand, focusing on APIs and Dosage manufacturing. The Mysore manufacturing site, spread over 69 acres, is a USFDA approved facility specializing in manufacturing APIs for Lifestyle driven Therapeutic Areas. The Roorkee facility is state-of-the-art and approved by multiple regulatory bodies including USFDA, Japan PMDA, UK MHRA, TGA, WHO, and Brazil ANVISA. Both manufacturing units are supported by around 500 research and development professionals based in Noida and Mysore. The R&D department focuses on developing new products in API, Solid Dosage Formulations, Sterile Injectable, Semi-Solids Ointments, Creams, and Liquids. The company conducts all BA/BE studies in-house at an 80 Bed facility with global regulatory accreditations. JGL's Regulatory Affairs & IPR professionals ensure a unique portfolio of patents and product filings in regulatory and non-regulatory markets. The revenue of Jubilant Pharma has been increasing steadily, with INR 53,240 Million in the Financial Year 2018-19 compared to INR 39,950 Million in the Financial Year 2017-18. For more information about the organization, please refer to www.jubilantpharma.com.,